For Devon Grimmé of Prometheon Pharma, a key interaction at last year’s GCVCA Expo led to eMerge 2015, which led to an appearance on CNBC.
Since eMerge, Devon and his team have received the first patent for an innovative needle-free insulin patch, and discovered an innovative hair growth technology.
“With all these changes, we are very close to a deal with a major pharma company & continue attracting investors thanks to the exposure we received in Miami.”
Where will your journey lead?
Get more details at prometheonpharma.com
